Antimoniais empregados no tratamento da leishmaniose: estado da arte

AUTOR(ES)

Rath, Susanne, Trivelin, Luciano Augusto, Imbrunito, Talitha Rebecca, Tomazela, Daniela Maria, Jesús, Marcelo Nunes de, Marzal, Percy Calvo, Andrade Junior, Heitor Franco de, Tempone, André Gustavo

FONTE

Química Nova

DATA DE PUBLICAÇÃO

2003-08

RESUMO

Antimony preparations are the drugs of choice for the treatment of leishmaniasis over 90 years, a disease that currently affects 12 million people worldwide. Its introduction was based on 19th century concepts of therapeutic effects of metal salts as arsenicals and other metals, most of them abandoned due to toxic effects or better drugs. In the last three decades, there was a great improvement in the knowledge of cell biology and immunology of those infections, but chemotherapy has not been improved in the same strength. The structure and mechanism of action of the two pentavalent antimonial drugs of choice, meglumine antimoniate and sodium stibogluconate, are not well known and the contamination of those pharmaceutical by toxic contaminants have been verified.

Documentos Relacionados

• 22. Estado da Arte no Tratamento da Leishmaniose Tegumentar Americana no Brasil
• Tratamentos antimoniais da leishmaniose
• Estudo dos conhecimentos, atitudes e práticas da leishmaniose: evidências da negligência do Estado no Darién colombiano
• "Estado da arte" no tratamento da leucemia linfocítica crônica
• Estudos Sobre Leishmaniose: I. Primeiros Casos de Leishmaniose Espontânea Observados em Cobáios